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Abstract: A Near Infrared Spectral Tomography (NIRST) system has been
developed and integrated into a commercial Digital Breast Tomosynthesis
(DBT) scanner to allow structural and functional imaging of breast in vivo.
The NIRST instrument uses an 8-wavelength continuous wave (CW) laserbased scanning source assembly and a 75-element silicon photodiode solidstate detector panel to produce dense spectral and spatial projection data
from which spectrally constrained 3D tomographic images of tissue
chromophores are produced. Integration of the optical imaging system into
the DBT scanner allows direct co-registration of the optical and DBT
images, while also facilitating the synergistic use of x-ray contrast as
anatomical priors in optical image reconstruction. Currently, the total scan
time for a combined NIRST-DBT exam is ~50s with data collection from 8
wavelengths in the optical scan requiring ~42s to complete. The system was
tested in breast simulating phantoms constructed using intralipid and blood
in an agarose matrix with a 3 cm x 2 cm cylindrical inclusion at 1 cm depth
from the surface. Diffuse image reconstruction of total hemoglobin (HbT)
concentration resulted in accurate recovery of the lateral size and position
of the inclusion to within 6% and 8%, respectively. Use of DBT structural
priors in the NIRST reconstruction process improved the quantitative
accuracy of the HbT recovery, and led to linear changes in imaged versus
actual contrast, underscoring the advantages of dual-modality optical
imaging approaches. The quantitative accuracy of the system can be further
improved with independent measurements of scattering properties through
integration of frequency or time domain data.
©2012 Optical Society of America
OCIS codes: (120.3890) Medical optics instrumentation; (170.4580) Optical diagnostics for
medicine; (170.6510) Spectroscopy, tissue diagnostics; (170.7440) X-ray imaging.
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1. Introduction
Digital Breast Tomosynthesis (DBT) is an emerging FDA-approved imaging modality for
breast cancer screening [1–3]. The technique is similar to conventional mammography in that
it images variations in breast density using x-ray attenuation and requires significant
compression to enhance soft tissue contrast. Importantly, DBT extends the capabilities of
conventional mammography by acquiring x-ray projection data at a limited set of angular
views, which allows 3D reconstruction of tissue density over the imaged breast volume. The
concept is related to conventional Computed Tomography (CT), but with limited angular
sampling. DBT provides superior lateral resolution, but its depth discrimination is relatively
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poor (typically about 1 mm resolution) because of the restricted angular views, which also
can cause artifacts such as ghosting. Nevertheless, DBT provides depth-resolved 3-D
structural images of the breast at a dose comparable to digital mammography, but with
improved diagnostic power [4].
Near Infrared Spectral Tomography (NIRST) acquires optical projection data at multiple
wavelengths for reconstruction of functional parameters such as hemoglobin concentration,
tissue oxygenation, fat content and water fraction, which are known to be sensitive to
neoplastic changes in tissue. Since light transport in this regime is dominated by scattering,
NIRST images are diffuse and lack high-resolution spatial detail, but when viewed in
conjunction with a high resolution structural imaging modality, can provide complementary
physiologic information to potentially improve overall diagnostic accuracy. This general
approach of combining a structural imaging modality with a functional imaging technique has
gained significant traction in recent years with several dual modality approaches being
developed and tested clinically including optical imaging combined with MRI, Ultrasound,
Mammography and DBT [5–9]. The most clinically successful implementation of dual
modality imaging has been the combination of Positron Emission Tomography and Computed
Tomography (PET-CT), where lower resolution PET imaging provides functional contrast to
supplement higher resolution structural CT.
In this study, NIRST is integrated into a commercial DBT system to allow tomographic
recovery of hemoglobin parameters in local regions of the breast. The combined NIRST-DBT
platform can provide co-registered functional information that could be synergistically
interpreted with the DBT images to improve diagnostic accuracy. In particular, NIRST
images could improve specificity in delineating malignant from benign masses, which is
relatively difficult in women with dense breasts, and leads to the high false positive rates
currently observed in mammography and DBT. The combination of NIRST and DBT was
first developed at the Massachusetts General Hospital (MGH) [8]. In a recently published
study, the MGH system examined 125 women and the results showed statistically significant
differences in hemoglobin concentration in malignant versus benign masses relative to the
fibroglandular region in the same breast [7]. The system consisted of an array of optical
fibers, which deliver and collect light from discrete locations on the top and bottom surfaces
of the compressed breast. Both continuous wave (CW, 3 wavelengths) and frequency domain
(FD, 2 wavelengths) projection measurements were made to allow tomographic
reconstruction of functional optical images. While the MGH design is effective, it is complex,
expensive and not readily scalable. The NIRST-DBT system described here takes a different
design approach, which is cost-effective, offers better integration with DBT and is simpler to
implement. The focus is primarily on CW imaging based on tomographic projection
measurements acquired at multiple wavelengths with provisions for adding limited FD
recordings optimized to the design. Other breast-imaging approaches with a similar emphasis
on CW imaging with solid-state detectors have been developed in the recent years [10,11].
2. Materials and methods
2.1 NIRST system instrumentation
The NIRST system was fabricated to attach to a commercial Digital Breast Tomosynthesis
scanner (Genesis Dimensions, Hologic Inc., CT). A schematic of the NIRST system
components is shown in Fig. 1(a). The source module is comprised of eight fiber-coupled,
temperature controlled laser diode units (Power Technology, NY) with individual emission
wavelengths at 660, 785, 808, 830, 852, 905, 915 and 940 nm. These specific wavelengths
were selected for spectral un-mixing of oxy-hemoglobin, de-oxy hemoglobin, water and fat
absorption spectra from combined measurements [12,13]. Each microprocessor-controlled,
temperature-stabilized laser unit is individually addressable through a standard RS-232
communication protocol.
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Fig. 1. (a) Schematic of the NIRST/DBT imaging system. (b) Photograph of the fully
assembled NIRST/DBT system installed at the Dartmouth-Hitchcock Medical Center
(DHMC). (c) Photograph showing the silicon photodiode detector panel inserted into the
custom designed cassette assembly to allow easy insertion and removal of the panel during
sequential DBT/NIRST scans. (d) Photograph of the 2- axis galvanometric scanning mirror
assembly mounted adjacent to the x-ray emission port on the DBT scanner. The source unit
allows arbitrary positioning and scanning of laser light beams onto the compressed breast
surface without obstructing the x-ray field-of-view.

A USB to 8-port RS-232 adapter (CPS) allowed a single USB port on the instrument
computer to control the operating parameters of the eight lasers. Two-hundred micron core
diameter multimode optical fibers were used to couple light from individual lasers into a 9x1
piezoelectric fiber optic switch (FSM 9x1-200, OptoJena, MA), which allowed fast sequential
switching of the lasers into a single 200 micron core diameter output optical fiber. The output
optical fiber is coupled into a computer controlled fiber optic attenuator (DD-100 series,
OzOptics, Canada), which adaptively attenuates the light output appropriately to differences
in attenuation properties between individual breasts. The output from the attenuator is
coupled to a fiber optic collimator (FC) to produce a collimated beam of light of
approximately 5mm in diameter, which diverges slightly due to the finite size of the source
optical fiber. A pair of orthogonally mounted galvanometric scanners (GS) with 5mm scan
mirrors (Cambridge Systems, MA) is used to direct and scan this beam over the surface of the
breast through the transparent polycarbonate compression paddle (TCP) of the DBT system as
shown in Fig. 1(a), resulting in a source-light spot diameter at the imaging plane of
approximately 8 mm. The source assembly containing the FC and GS is permanently
mounted beside the x-ray port on the DBT such that it does not interfere with DBT exposures.
The independently controlled scanners allow arbitrary positioning of the source beam over the
top surface of the compressed breast, but a standard raster scanning pattern was used in all
experiments described in this work.
The detector panel (DP) consisting of a matrix of 75 large-area silicon photodiodes was
custom fabricated. The individual photodiode units (S9270, Hamamatsu Corp., Japan) have
1cm x 1cm active areas with high gain transimpedance amplifiers built into each diode
package. The diode is configured to produce 0-10 V signal range, which is digitized directly
using a standard off-the-shelf 80-channel Analog-to-Digital Converter (ADC, USB-6255,
National Instruments, TX), without the need for additional signal conditioning. A custom
printed circuit board (PCB) was designed to interface the photodiode outputs to the analog
input channels of the ADC through a pair of 68-pin standard Small Computer System
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Interface (SCSI) connectors. A six-layer PCB design was used to isolate the power, signal,
and ground planes to minimize noise coupling. A single −10V-0-10V dual mode linear power
supply (Acopian, US) was used to power the detectors. Since the photodiodes were driven
from a single power supply, 0.1µF ceramic decoupling capacitors were included to isolate
individual photodiodes from transient loading effects and power-line fluctuations. Noise floor
measurements indicated that the detector panel offers a full-scale dynamic range of
approximately 51 dB.
Since the detector panel is not transparent to x-rays, simultaneous NIRST/DBT imaging is
not possible at this time. Hence, imaging is performed sequentially, where the detector panel
is inserted into the field-of-view during the optical scan and removed during the DBT scan.
To facilitate panel insertion/removal, a custom-designed detector cassette assembly (DC) was
fabricated into the DBT base plate to allow the detector panel to slide in and out of the field
without altering the breast position. The cassette was also designed to allow the detector panel
to be inserted from either side of the scanner to accommodate left or right breast imaging. A
photograph of the detector panel inserted into the cassette assembly is shown in Fig. 1(c).
2.2 Data pre-processing and calibration
The response of individual silicon sensors in the detection panel to a uniform field of light
was measured to characterize differences in sensitivity. Since the detectors were mounted on
a panel, a special calibration puck was designed to expose each of the detector units to a
uniform field of light and record the corresponding voltage signal. The calibration puck
consisted of an optical fiber light source coupled to a homogeneous diffuse resin phantom
with a raised square notch machined on the top surface that allowed precise, repeatable
alignment of this surface with the active area of the exposed detector.
A schematic of the measurement configuration and the calibration puck are shown in Figs.
2(a) and 2(b), respectively. Three individual measurements were made on each detector by
removing and re-inserting the calibration puck and the average response was used for
calibration. Detector number 5 was arbitrarily chosen as the reference and the signal strengths
from the other sensors were referenced to its value to obtain a correction factor for the
individual detectors. Figure 2(c) shows a plot of the correction factor for each of the 80
detectors characterized. No correction factors were needed on the source side as the
differences in source strengths across the entire imaging field were measured and found to be
negligible.
In a typical data collection sequence, measurements from all detectors were recorded for
each source position. The data acquisition system used a front-end 80x1 analog multiplexer to
digitize all the 75 measurement channels sequentially (5 ADC channels are left unused).
While this analog multiplexing scheme leads to simple and cost-effective data acquisition, it
is prone to isolation artifacts, where a high voltage signal on a particular channel could
corrupt measurements in an adjacent channel carrying a low voltage signal. These
inaccuracies were detected and eliminated automatically by analyzing relative signal strengths
in all adjacent channel pairs and applying an empirical threshold determined from a series of
homogeneous phantom measurements. An overall path-length threshold was also used to
exclude noisy data from detectors that were far from the illumination source position.
Currently, for a homogeneous 260 x 180 x 60 mm test phantom (BioMimic, Institut national
d'optique, Canada) with µa = 0.01 mm−1 and µs’ = 1 mm−1 at 830 nm, a path-length limit of
100 mm is used, which corresponds to lateral distances of up to 80 mm from directly beneath
the source position. Figure 2(d) shows the raw data measured from the test phantom at 660
nm and 785 nm wavelengths and the processed data used for image reconstruction is shown
in Fig. 2(e).
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Fig. 2. (a) Schematic showing the calibration puck positioned over an individual detector
element in the detector panel. (b) Schematic drawing of the calibration puck showing a square
notch on top that allows repeatable positioning over each detector element. (c) Correction
factor for each of the 75 detector elements showing variations in individual detector response
(certain detector channel numbers are unused). (d) Raw tomographic projection data plotted as
a function of source-detector separation acquired from a homogeneous test phantom at 660 nm
and 785 nm wavelengths. (e) Processed data showing the removal of signal artifacts.

2.3 Measurement geometry and co-registration
Co-registration of the optical scan with the DBT field is achieved by using the DBT
compression paddle (CP) as a common frame of reference. The optical beam is incrementally
scanned in the X and Y directions in 2 cm intervals. Since the height of the compression
paddle changes for every patient, the scan angles are adjusted automatically, using simple
trigonometry calculations, to preserve the scan geometry at any given height of the
compression paddle. The optical scan position accuracy was verified manually with a
rectangular grid pattern of 2 cm x 2cm spacing overlaid on the top compression paddle. The
phantoms were placed at a known fixed position relative to the detector panel, which allowed
calculation of the individual detectors positions.
2.4 Blood-intralipid phantom preparation and imaging
Breast tissue simulating intralipid and blood phantoms were created in an agarose matrix.
Type 1 agarose powder was mixed in phosphate buffered saline (PBS) at a ratio of 0.02 g/ml
and heated in a microwave oven to bring the solution to a rolling boil. An appropriate
quantity of 20% intralipid solution pre-mixed to achieve 1% volume fraction of lipids overall
was added to the PBS-agarose stock solution and the mixture was transferred to a stir plate,
where it was continuously stirred until it cooled to ~38°C. Porcine blood was then added to
this mixture at an appropriate dilution to achieve ~15 uM hemoglobin concentration overall.
This mixture was stirred for a minute and then transferred into a mold for casting. The
mixture was refrigerated for approximately 30 minutes in the mold and then removed for
measurements. The concentration of intralipid and hemoglobin used here results in optical
properties comparable to that of a typical breast. For fabricating inclusions, a cylindrical tube
with a flat covered base was suspended to a predetermined depth at the position of interest,
before the mixture began solidifying. The tube was removed after the phantom solidified to
leave a cylindrical hole, which was filled with liquid contrast inclusions.
A homogeneous 24 cm x 16 cm x 5.2 cm block of solid phantom and an inclusion
phantom with the same overall dimensions were cast with the same background optical
properties using the procedure described above. The cylindrical inclusion measured
approximately 3 cm in diameter and 2 cm in depth and its center was located 7 cm from the
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bottom edge and 8.4 cm from the left edge of the phantom block as shown in the schematic in
Fig. 3(a). An additional 24 cm x 16 cm x 1 cm block was cast to act as a stacking layer, which
when placed on the inclusion phantom positioned the heterogeneity 1 cm below the top
surface. This stacked phantom design also allowed the top layer to be easily removed, which
facilitated the creation of liquid inclusions with different hemoglobin and lipid contrast values
relative to the homogeneous background. Photographs of the homogeneous top layer and
inclusion phantom casts are shown in Fig. 3(b). The overall thickness of the phantom was 6.2
cm, which is representative of typical maximum breast thicknesses achieved through
compression during mammography exams [14].

Fig. 3. (a) Schematic of the intralipid/blood inclusion phantom construct which is 24 cm (in the
X-direction) by 16 cm (in the Y-direction) by 5.2 cm (in the Z-drection). (b) Photographs of
the fabricated top and bottom layers of the phantom and the addition of a liquid inclusion.

Liquid inclusions with hemoglobin contrasts of 2:1, 3:1 and 4:1 were imaged relative to
the background hemoglobin concentration of 15 µM. A 1% intralipid stock solution was used
in all cases, fixing the scatter contrast to 1:1. A homogeneous phantom measurement was
obtained by filling the inclusion with 1% intralipid stock solution containing 15 µM of
hemoglobin matching the absorption and scatter properties of the background. The
homogeneous phantom measurements served as a calibration for the contrast phantom data
and account for variations in source strengths across the measured wavelengths [15–17]. The
eight-wavelength scan time for each phantom was approximately 42s.
2.5 NIRST image reconstruction
The NIRFAST software package version 7 was used to reconstruct the chromophore images
directly with a spectrally constrained inversion algorithm [18]. Its finite element method
(FEM) image reconstruction process is described in detail elsewhere [19]. FEM meshes
representing the homogeneous and contrast phantoms were created with a 3-D meshing
algorithm developed in-house. Three-dimensional (3D) diffuse reconstruction of total
hemoglobin concentration was performed from data on 2:1, 3:1 and 4:1 contrast phantoms.
Images of total hemoglobin concentration (HbT), oxygenation, water fraction and fat content
were recovered from the experimental data calibrated with the reference phantom
measurements.
The diffuse reconstruction process is ill posed often leading to poor quantitative accuracy
of the recovered contrast. Another approach to reconstructing the chromophore contrast
applies prior knowledge of the size and location of the heterogeneity in the reconstruction
problem to recover chromophore concentrations from these pre-defined “regions-of-interest”
[20]. The region-guided approach provides better quantitative accuracy through reduced
dimensionality of the inverse problem, but also assumes optical property homogeneity within
the defined regions. The method is known to improve diagnostic performance in multimodality imaging frameworks, such as the NIRST-DBT system described here, where
accurate anatomic information is available [20].
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3. Results
3.1 NIRST-DBT system performance
Table 1 summarizes key performance metrics of the NIRST-DBT system. The dynamic range
of the detection panel was calculated from the measurements of the maximum and minimum
signal levels that could be detected. The maximum dynamic range offered by the detection
panel was ~59.6 dB. However in the presence of other noise sources the effective dynamic
range is reduced to about ~50.1 dB. Table 1 also shows signal to noise ratio (SNR) values for
a typical source-detector projection measurement producing a nominal signal range of ~1-2V.
This metric was computed from the mean and standard deviation of 5 independent, calibrated
projection measurements made on a homogeneous phantom, to provide an assessment of the
overall fidelity of the raw measured signals.
Table 1. Key Performance Parameters of the NIRST-DBT System
Parameter
Detector dynamic range
(dB)
Effective detector
dynamic range (dB)
Typical SNR at nominal
signal level of ~1-2V (N =
5) (dB)

Value

NIRST scan time

42 s (~5s per wavelength)

DBT scan time

6s

59.6
50.1
660
nm
15.8

785 nm
30

808
nm
30.9

830
nm
37.6

852
nm
34.4

905
nm
29.1

915
nm
30.9

940
nm
24.2

3.2 Diffuse image reconstruction of blood contrast phantoms
A 3D FEM mesh was created in NIRFAST based on the phantom dimensions and the relative
positions of the sources and detectors. A diffuse, spectrally constrained, chromophore image
reconstruction was performed on the data from phantoms with 2:1, 3:1 and 4:1 HbT contrast
in the inclusion relative to the background hemoglobin concentration of 15 µM. A fixed
regularization value of 0.1 was applied in a modified Newton-type inversion implemented in
NIRFAST. The scatter properties were defined and fixed in the CW reconstruction process
and the µs’ values for 1% intralipid solutions were obtained from empirical relations
described in [21].
Since blood is the primary contrast in these phantoms only HbT images are presented
here. Figure 4 shows the X-Z (Figs. 4(a)-4(d)), X-Y (Figs. 4(e)-4(h)) and Y-Z (Figs. 4(i)-4(l))
cross-sectional views of the actual location of the contrast and the reconstructed total
hemoglobin images in the same views for the 2:1, 3:1 & 4:1 contrast phantoms. Figure 4(m)
contains a line plot in the X direction across the center of the contrast region in the X-Y
images shown in Figs. 4(f)-4(h). Figure 4(n) presents a line plot in the Y direction in a region
beyond the inclusion (see dotted line in Fig. 4e), where some change in recovered hemoglobin
is observed across the phantom background.
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Fig. 4. X-Z (a-d), X-Y (e-h), and Y-Z (i-l) cross-sectional views (see Fig. 3(a) for phantom
coordinate system) of the reconstructed HbT images in the center of the inclusion region for
the 2:1, 3:1 and 4:1 contrast phantoms. (m) Horizontal (X-direction) line plot through the
center of the contrast region (see dotted line in (e)) for the three contrast phantoms (A = 2:1; B
= 3:1; C = 4:1). (n) Vertical (Y-direction) line plot showing HbT concentration through the
center plane of the phantom inclusion (see dotted line in (e)).

3.3 Region-guided reconstruction of intralipid/blood contrast phantoms
The presence of an HbT gradient in the background region did not allow for region-based
recovery of HbT from the first set of phantom experiments; hence, another set of contrast
phantoms with 1:1, 2:1 and 3:1 HbT contrasts were cast and were measured on the NIRSTDBT system. The inclusion-to-background scatter contrast was set to 2:1, and the equivalent
scattering properties for these regions were assigned based on literature values [21], and were
constrained to remain fixed during the reconstruction process to minimize potential crosstalk
between scatter and absorption signal recovery. Care was taken during the setting process to
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ensure that the phantom molds were placed on a level surface to minimize variations in
phantom thickness and to maintain mixture homogeneity.

Fig. 5. X-Y cross-sectional views of the reconstructed HbT images for the 1:1 (a), 2:1 (b), and
3:1 (c) contrast phantoms. (d) Cut-away view of the FEM mesh showing the background and
inclusion regions. (e) Plot of recovered HbT contrast in the background (solid triangles) and
inclusion region (solid circles) vs actual HbT concentration in the background and inclusion.
Linear fits show that the HbT concentration is nearly constant in the background and varies
linearly in the inclusion as expected.

Figure 5 shows results from region-guided recovery of total hemoglobin contrast in 1:1,
2:1 and 3:1 contrast phantoms. Figure 5(d) provides a cut-away view of the FEM mesh and
the inclusion region inside. Figures 5(a)-5(c) contain X-Y cross-sections of the recovered
total hemoglobin image through the inclusion region for each contrast phantom. Figure 5(e)
plots the recovered HbT as a function of the actual values in the phantom inclusion and
background.
4. Discussion
This paper describes the design, development and integration of NIRST into a commercial
DBT scanner. Agarose-based intralipid and blood contrast phantoms were fabricated to
demonstrate the imaging capabilities of the NIRST component of this multi-modality
platform. When no spatial priors were used in the reconstruction process, the recovered HbT
concentration in the background region was approximately 73% of the actual concentration
for three contrast cases. The recovered peak HbT concentration in the inclusion region was
approximately 41%, 29% and 26% of the actual HbT concentrations, respectively. The
recovered centroid location of the contrast was approximately 6.3, 6.6 and 6.8 cm from the
edge of the phantom, which is close to the actual location of the inclusion (7 cm from the
edge). A full-width at half maximum (FWHM) criterion was used to analyze the size of the
contrast from the Z-plane (depth) images and the recovered sizes were approximately 3.4, 3.2
and 3.1 cm (which is close to the actual inclusion diameter of 3 cm). The size of the recovered
contrast appears to be larger than that of the actual contrast in the Z-direction, where it
extends to the surface, likely due to the more modest imaging resolution in the depth
direction, which is common in the transmission imaging mode used here.
An overall gradient in HbT in the Y direction was also observed in the background, which
is visible in the X-Y cross-sectional images in Fig. 4. Figure 4(n) shows a line plot of HbT
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concentration along this gradient, which indicates that the magnitude of the effect is similar in
all three imaged phantoms despite their inclusion contrast differences. The X-Y cross
sectional images also show that the direction of this gradient is similar and consistent in each
of the three phantoms. A similar gradient was observed in the raw projection data (not shown
here) suggesting either a gradient distribution in hemoglobin concentration existed in the
actual phantom or variation occurred in the phantom thickness in this direction. While the
occurrence of a gradient distribution in HbT concentration is unlikely with the fabrication
methods applied, a linear change in phantom thickness could easily be induced if the phantom
molds were not level during the setting process. Forward data simulations performed in slab
meshes with varying Z thickness and constant optical properties matching that of the
measured phantoms indicate that a 2-3 mm change in thickness could cause the magnitude of
forward data change observed in the experimental phantoms. The large slab phantoms used
here are soft when cured and are compressible, which likely made it hard to notice this small
but significant height change.
In the case of region-guided image reconstructions, the background concentration of HbT
was consistent and equal to approximately 67% of the actual concentration. The recovered
HbT concentration in the inclusion region was slightly over-estimated (around 110% of the
actual concentration) in the 1:1 HbT contrast case, and was approximately 74% of the actual
concentration in the 2:1 and 3:1 contrast cases. Figure 5(e) also shows that the recovered peak
HbT concentration in the inclusion region increases linearly with actual HbT concentration,
while the recovered background HbT concentration remains nearly constant throughout, as
expected. For the no-HbT contrast case (1:1), the recovered HbT value was overestimated and
created an artificial contrast. The recovered contrast values are approximately 1:1.6, 1: 2.2
and 1:3.1 respectively, compared to the actual values of 1:1, 1:2 and 1:3. Even though the
recovered contrast matches the true contrast values for the 1:2 and 1:3 cases closely, it should
be noted that the absolute HbT concentrations for the background and inclusion regions were
equally underestimated by ~25-30% in both these cases. These deviations in reconstructed
HbT concentration values are likely caused due to a combination of several effects including,
mismatch in the refractive index between the gelatin background and the liquid inclusions and
mismatch in the specification of scatter properties obtained from literature recipes [21], which
could result in a cross-talk between scatter and absorption parameters, and numerical artifacts
caused by fixing the scatter properties during the CW reconstruction process. However, the
region-guided approach provided a consistent recovery of hemoglobin parameters in the
background and inclusion regions overall.
The optical scan time for single wavelength imaging is currently ~5 s, which is
comparable to the DBT scan time. However for spectral imaging using 8 wavelengths the
overall scan time increases to approximately 42 s, as the wavelengths are sequentially
scanned. Reduction in overall scan time is possible through wavelength multiplexing
approaches, but the large area silicon photodiodes used here are not fast enough to allow
implementation of commonly used time or frequency based multiplexing strategies. As an
alternate, avalanche photodiodes (APD) offer much higher photon sensitivity and have better
dynamic response, but integration of APDs into this form factor would lead to significantly
increased instrumentation complexity and cost. APDs are also inherently noisier compared to
silicon photodiodes, which could impact signal-to-noise ratio (SNR) and dynamic range, so it
is not readily clear whether an APD based detector panel would offer significant
improvements in scan time at a comparable SNR to justify increased cost and instrumentation
complexity. Small scale testing of other types of silicon photodiodes and post-processing
circuitry are currently underway to optimize the detection panel for the subsequent design
iteration of the NIRST system.
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5. Conclusion
Integration and co-registration of DBT and NIRST imaging allow synergistic structural and
functional imaging of breast abnormalities, which could improve diagnostic accuracy overall.
Success with this approach depends on how well the NIRST technology can be integrated into
existing workflow for clinical DBT imaging. The major focus of this first generation NIRSTDBT imaging system design was to balance integration and imaging performance with
instrumentation complexity and cost. Creation of a high sensitivity, multi-element, solid-state
detector panel, along with a simple, permanently mounted non-contact source scanning
assembly offers high-speed scanning, compact DBT integration and reduced instrumentation
complexity. Results from contrast phantom studies demonstrate the ability of the system to
detect and localize hemoglobin contrast. While the diffuse image reconstructions recovered
the approximate position and size of the HbT contrast, the quantitative performance in terms
of actual property values was not optimal. The use of prior information on the size and
location of the contrast in the reconstruction algorithm improved the quantitative optical
property performance significantly, which underscores the benefits of dual modality optical
imaging platforms, such as the one described here. Knowledge of optical scattering properties
is important to accurate recovery of hemoglobin values. The CW system implemented here is
not capable of measuring scatter signals directly, but could be augmented with some
frequency domain (FD) measurements if necessary. Several design approaches are being
considered, and an important tradeoff is the number of FD measurement channels and
wavelengths needed for robust sampling of scattering properties across the breast. A separate
study [22] of scattering properties effects on the quantitative recovery of hemoglobin contrast
suggests that limited, region-averaged sampling of scatter properties is sufficient for accurate
reconstruction of hemoglobin contrast. Another interesting approach is to map optical scatter
properties to tissue density images acquired with DBT. Tissue density is known to affect its
optical scattering response, but a complete mapping between optical and DBT images is not
trivial, mainly because DBT images are typically not quantitative. Significant efforts have
been underway to make DBT imaging quantitative [23, 24], and advances could impact the
design and integration of DBT coupled optical imaging in the future.
The phantom imaging experiments described here involved a fixed-size for the inclusions
and the lateral and depth positions were also fixed. Though these experiments provided an
initial quantitative assessment of the performance of the imaging instrumentation, a more
extensive evaluation would generate contrast-detail analyses, where both the size and the
location of the contrast are changed. The phantom design outlined here is not suitable for this
type of characterization, which is required for a comprehensive analysis of diagnostic
performance using standard receiver operating characteristic (ROC) metrics. Currently, a
multilayer, stackable, spectral resin phantom is being designed in collaboration with the
Institut National d'Optique (INO, Quebec, Canada) to facilitate the imaging of different
contrast sizes at multiple depth locations in order to complete this analysis in the future.
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